An Australian pharmacy is typically worth 3–5x EBITDA, or somewhere between 1.0x and 1.5x annual gross profit — but those multiples swing hard depending on where you’re located, how your lease is structured, and what the last 24 months of PBS script volumes look like. A medical centre pharmacy in a growth suburb of Perth or Melbourne is a genuinely different asset from a strip pharmacy in a declining rural town, even if both are doing similar top-line numbers.
If you’re thinking about selling, retiring, or just trying to understand what you’ve actually built, this is how the valuation works.
How Pharmacies Are Valued in Australia
There are two methods buyers use, and most serious buyers apply both as a cross-check.
EBITDA multiple. You take earnings before interest, tax, depreciation, and amortisation — and you add back the owner’s salary to a market rate, personal expenses run through the business, and genuine one-offs. Then you apply a multiple. For a standard community pharmacy, that multiple sits between 3x and 5x. For a medical centre pharmacy with strong GP co-location and solid script growth, buyers have paid 6x and above. For a standalone strip pharmacy with a lease coming up for renewal and flat scripts, 2.5x is realistic.
Gross profit multiple. Because dispensing margins are relatively standardised by the PBS, gross profit is often a more stable anchor than EBITDA (which can be distorted by the owner’s draw). A pharmacy generating $600,000 in annual gross profit sitting at a 1.2x multiple is worth $720,000. This method is widely used because it’s harder to manipulate than a net profit figure.
Both methods should produce a similar answer. If they’re diverging dramatically — say the EBITDA method produces a number 40% higher than the gross profit method — something unusual is happening in the cost structure, and a buyer will find it.
The old rule of thumb — “a pharmacy is worth one times its turnover” — has largely been abandoned. Revenue multiples don’t account for gross margin at all, and the difference between a 28% gross margin pharmacy and a 35% gross margin pharmacy is enormous once you’re working with EBITDA.
The Factors That Actually Move the Price
Script volume trends matter more than the absolute script count. A pharmacy doing 2,500 scripts per month with 18 months of flat-to-declining volume is a worse asset than one doing 2,000 scripts per month with clear upward trajectory. Buyers are buying the future, not the past, and they know it.
Front-of-shop margin. Dispensing revenue pays the rent; front-of-shop (FoS) retail is where the margin lives. A pharmacy that has invested in vitamins, skincare, compounding, or allied health services — and has the gross margin numbers to prove it — commands a premium. A dispensary masquerading as a pharmacy, with half-empty shelves and a FoS gross margin under 35%, does not.
Staffing model. A pharmacist must be on the premises any time the dispensary is open. This means the business is inherently dependent on pharmacist labour. Buyers want to see a practice where the owner-pharmacist isn’t working 55 hours a week covering every shift themselves. An established dispensary team with trained assistants and a part-time locum arrangement signals a business that can continue without you — and that’s what generates a real multiple.
Regulatory approvals. Your pharmacy approval isn’t transferable; the incoming owner will need their own. But the location approval matters enormously to value — if your site has been approved and established in a high-demand area, that represents a barrier to competition that a buyer is paying for. This is also why the lease is so critical (more on that below).
What Buyers Are Actually Looking For
A trade buyer — another pharmacist or small pharmacy group — will stress-test your PBS mix. They know the dispensing fee structure better than most accountants, and they’ll look hard at whether your script growth is genuine or driven by one or two high-volume patients who might not survive a change of ownership.
A financial buyer (private equity, pharmacy roll-up group) will run a normalised EBITDA model and layer in synergy assumptions — better buying terms, shared back-office, group branding. These buyers sometimes pay more, but they also take longer and do more thorough due diligence.
Both types of buyers look hard at:
- 24 months of PBS reports — script volume by category, dispensing fee income, brand/generic split
- Gross profit by department — dispensary vs FoS vs compounding vs services
- Staffing costs as a percentage of gross profit — should typically be under 55% of GP for a well-run practice
- Lease terms — covered separately below, because this is often the biggest value variable of all
- Compliance record — PSA audits, Pharmacy Board matters, PBS compliance
I saw a pharmacy sale recently where the vendor had strong scripts and a clean fit-out — everything looked right on paper. When the buyer’s accountant pulled the PBS reports, there was a concentration issue: roughly 30% of the dispensing revenue came from three nursing home medication supply contracts, none of which had written renewal agreements. The buyer repriced immediately. The vendor got what they were going to get anyway, minus six weeks of negotiation and a lot of goodwill. Get those contracts documented before you start a sale process.
The PBS Reform Problem: What 60-Day Dispensing Did to Values
In August 2023, the Australian government expanded 60-day dispensing to allow patients to receive a two-month supply of eligible medicines in a single dispensing. For pharmacies, this was a revenue event — fewer scripts dispensed means fewer dispensing fees collected. Industry estimates at the time suggested a 15–25% reduction in script volumes for affected medicines.
If your pharmacy was heavily exposed to the medications covered by 60-day dispensing (blood pressure, cholesterol, diabetes, thyroid — the chronic disease staples), you will have seen a direct hit to your top line. That decline will appear in your historical financials and buyers will see it.
This doesn’t mean your pharmacy is unsaleable or that you’ve lost a third of your value. But it does mean that buyers will want to understand the current run-rate, not just the historical average — and that the years before 2023 may need to be treated differently in a valuation model. Work with an advisor who understands the PBS reform context; using a three-year simple average without adjustment will undervalue your current trading position if you’ve stabilised post-reform.
The Lease Question: Why Your Landlord Matters as Much as Your Scripts
This is the part that catches pharmacy owners off-guard. Your lease — its term, its rent, and your relationship with the landlord — can be the difference between a $1.2 million sale and a $900,000 sale. For a medical centre pharmacy, the co-location agreement with the centre operator is arguably the most valuable asset in the business.
Here’s why this matters so much in pharmacy specifically: unlike most businesses, a pharmacy can’t simply relocate without regulatory approval. If your lease expires and you have to move, you’ll need a new site approval — and there’s no guarantee a new location will deliver the same script capture. Buyers know this. A short remaining lease on a high-rent premises, with no renewal option agreed, is a red flag that experienced buyers reprice immediately.
What buyers want to see:
- A lease with at least five years remaining, ideally with a five-year option on top
- Rent that represents no more than 8–10% of gross profit (higher than this and the economics get very tight for a buyer servicing acquisition debt)
- A co-location agreement with the medical centre (if applicable) that is in writing, transferable on change of ownership, and has a meaningful term left
- A landlord relationship that isn’t going to blow up the deal — a landlord who refuses to consent to a lease assignment is, inconveniently, entirely within their rights in many situations
Talk to your landlord before you engage an advisor. Not to tell them you’re selling — just to understand where you stand.
Tax: The Bit That Changes the Actual Number in Your Account
The sale of your pharmacy will likely generate a significant capital gain. Whether you’re selling shares in your company or the assets of the business matters a great deal to how much tax you pay. Most pharmacy sales are structured as asset sales, because buyers want a clean start without inheriting the entity’s history. But the asset sale vs share sale question is worth thinking through carefully, because the tax treatment of goodwill, equipment, and stock are all different.
The small business CGT concessions — the 15-year exemption, the retirement exemption, the 50% active asset reduction — can dramatically reduce your tax bill if your structure qualifies. These aren’t automatic. They require the right entity structure and the right planning, ideally started at least 12 months before you sell.
How to Prepare Your Pharmacy for Sale
You can genuinely increase what a buyer will pay, and you don’t need 24 months of runway to do it.
Lock in the lease first. Everything else is secondary to this. If your lease has less than four years remaining, approach your landlord now and negotiate an extension before you go to market. A pharmacist selling with a three-year lease and no option will get a much harder conversation from every buyer.
Then document everything buyers are going to ask for anyway: three years of financials (clean, with add-backs clearly listed), 24 months of PBS reports, all supplier agreements, all employment contracts, and the lease itself. Having this ready at the start shortens your sale timeline by months — and a shorter process is a lower-risk process for everyone.
Reduce owner dependency. Even if it’s just three months of demonstrating that your head pharmacist runs the dispensary without you there every day, it matters to a buyer who is financing the acquisition.
Finally, understand what buyers are actually looking for in a small business purchase before you go to market. A pharmacy is a regulated, location-dependent business with specific industry dynamics. The buyers who will pay you a real multiple know the industry cold — so should you.
What Your Pharmacy Is Actually Worth
If you want a rough number before you’ve had any formal conversations, our valuation calculator will give you an indicative range based on your revenue, gross margin, and business structure.
For a more detailed conversation — particularly if you’re within two to three years of retirement or thinking about bringing in a partner as a precursor to an exit — contact us directly. We work with business owners across Perth and around Australia, and we’ll give you a straight answer on what you’ve built and what it’s realistically likely to sell for.
Note: The articles how-much-is-my-professional-services-business-worth and small-business-valuation-methods-australia may benefit from linking to this article where pharmacy or healthcare valuations are mentioned.